Please ensure Javascript is enabled for purposes of website accessibility

Editas Medicine(EDIT)

Nasdaq Global Select

Editas Medicine Stock Quote
$34.11 -$0.23 -0.7%
Price as of May 7, 2021, 4:00 p.m. ET View Interactive EDIT Charts

Editas Medicine is a pioneer in gene editing technology. The biotech holds exclusive rights to CRISPR, a mechanism for cutting and pasting changes to DNA at precise locations.

Interactive Chart

News & Analysis: Editas Medicine

The Fool has written over 200 articles on Editas Medicine.


Market Moves